loader
Please Wait
Applying Filters...

Annual Sales of Cinacalcet reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 2,054Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Regpara

02 1Sensipar

03 1Sensipar /Mimpara

04 6Sensipar/ Mimpara

05 1Sensipar/Mimpara

PharmaCompass

01

Brand Name : Sensipar/ Mimpara

Cinacalcet Hydrochloride

arrow
FNCE 2024
Not Confirmed

Brand Name : Sensipar/ Mimpara

arrow
FNCE 2024
Not Confirmed

Cinacalcet Hydrochloride

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2020 Revenue in Millions : 288

2019 Revenue in Millions : 551

Growth (%) : -48

blank

02

Brand Name : Regpara

Cinacalcet Hydrochloride

arrow
FNCE 2024
Not Confirmed

Brand Name : Regpara

arrow
FNCE 2024
Not Confirmed

Cinacalcet Hydrochloride

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2020 Revenue in Millions : 115

2019 Revenue in Millions : 109

Growth (%) : 5

blank

03

Brand Name : Sensipar/ Mimpara

Cinacalcet Hydrochloride

arrow
FNCE 2024
Not Confirmed

Brand Name : Sensipar/ Mimpara

arrow
FNCE 2024
Not Confirmed

Cinacalcet Hydrochloride

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2021 Revenue in Millions : 84

2020 Revenue in Millions : 288

Growth (%) : -71

blank

04

Brand Name : Regpara

Cinacalcet Hydrochloride

arrow
FNCE 2024
Not Confirmed

Brand Name : Regpara

arrow
FNCE 2024
Not Confirmed

Cinacalcet Hydrochloride

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2021 Revenue in Millions : 87

2020 Revenue in Millions : 115

Growth (%) : -15

blank

05

Brand Name : Sensipar/ Mimpara

Cinacalcet Hydrochloride

arrow
FNCE 2024
Not Confirmed

Brand Name : Sensipar/ Mimpara

arrow
FNCE 2024
Not Confirmed

Cinacalcet Hydrochloride

Main Therapeutic Indication : Endocrinology

Currency : USD

2022 Revenue in Millions : 64

2021 Revenue in Millions : 84

Growth (%) : -24

blank

06

Brand Name : Regpara

Cinacalcet Hydrochloride

arrow
FNCE 2024
Not Confirmed

07

Brand Name : Regpara

Cinacalcet Hydrochloride

arrow
FNCE 2024
Not Confirmed

08

Brand Name : Sensipar /Mimpara

Cinacalcet Hydrochloride

arrow
FNCE 2024
Not Confirmed

Brand Name : Sensipar /Mimpara

arrow
FNCE 2024
Not Confirmed

Cinacalcet Hydrochloride

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2015 Revenue in Millions : 1,158

2014 Revenue in Millions : 1,415

Growth (%) : 22%

blank

09

Brand Name : Sensipar/Mimpara

Cinacalcet Hydrochloride

arrow
FNCE 2024
Not Confirmed

Brand Name : Sensipar/Mimpara

arrow
FNCE 2024
Not Confirmed

Cinacalcet Hydrochloride

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2017 Revenue in Millions : 1,718

2016 Revenue in Millions : 1,582

Growth (%) : 9

blank

10

Brand Name : Sensipar/ Mimpara

Cinacalcet Hydrochloride

arrow
FNCE 2024
Not Confirmed

Brand Name : Sensipar/ Mimpara

arrow
FNCE 2024
Not Confirmed

Cinacalcet Hydrochloride

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2018 Revenue in Millions : 1,774

2017 Revenue in Millions : 1,718

Growth (%) : 3%

blank